Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : EntreMed (ENMD) -- Ignore unavailable to you. Want to Upgrade?

To: Sam Citron who wrote (478)	5/4/1998 10:10:00 AM
From: Tech Master	Read Replies (1) \| Respond to of 2135

Sam- This is the mother of all shorts today.... this is old news... it is a rehash of the research paper to allow DH Blair to sell their whole damn position!

To: Sam Citron who wrote (478)	5/4/1998 12:42:00 PM
From: LTK007	Read Replies (1) \| Respond to of 2135

Sam,the big thing that is different as I see it,is the NIC --this is what uncorked this stock and set off a gusher. In the woulda,shoulda department,I have been aware of the great potential of angiostatin/endostatin,and of the great work of Dr.Judah Folkman for some time now.Once in awhile I'd say,geez I should buy some shares in ENMD,but then would say,wait for a new development and then go in--but I did NOT expect a MASSIVE National news breakout,nor for it to occur over a week end. My congratulations to all who were holding,if I had been one of you I would have sold in morning,then buy back in another day. But to all lurkers new to this thread let me say this--this is the real thing,this is no shallow hype.max90